FH Webinars

FH Summit 2024

The 20243 FH Summit provided updates in several areas of the management of FH, updated others on State-based activities and discussed the development of a risk-reduction pathway for children.

A report may be viewed here.

FH Summit 2023

The 2023 FH Summit  aimed to identify ways to improve the management of FH and to coordinate the improved treatment of this condition throughout Australia.

A report may be viewed here.

FH Summit 2022

The Familial Hypercholesterolaemia Australasia Network (FHAN) brought together a panel of international and Australian experts for a virtual summit in October 2022.  Video recordings are available via the links below. A report may be viewed here.

Children – Co-Chairs: Shubha Srinivasan/Ari Horton
New detection strategies: newborn screening	Amy Peterson (USA)
Model of care for children and adolescents	Ari Horton (VIC)
Consumer perspective	Jenny Della-Vedova (WA)
Management – Co-Chairs: Tom Brett/Karam Kostner
Achieving treatment targets in general practice	Nadeem Qureshi (UK)
Improving drug adherence	Natalie Raffoul (NSW)
New drugs for FH	Kausik Ray (UK)
Treatment of severe FH in children	Shubha Srinivasan (NSW)
Practical application – Co-Chairs: Jan Radford/Dorothy Graham
Genomics for the general practitioner	Sibel Saya (VIC)
Care pathways in general practice	Luke Elias (NSW)
Family planning and management of pregnancy	Jeanine Roeters van Lennep (Netherlands)
Implementation – Co-Chairs: Gerald Watts/David Sullivan
Implementing treatment guidelines	Laney Jones (USA)
Sonic National FH Program	Damon Bell (WA)
Role of Australian Genomics	Tiffany Boughtwood (VIC)
The 10-P FH Implementation Program	Mitchell Sarkies (NSW)
Workshops
Achieving treatment goals (adults)	Natalie Raffoul & Ann Carrigan (NSW)
Achieving treatment goals (children and adolescents)	Shubha Srinivasan & Carolyn Mazariego (NSW)
Integration of care with GPs	Jo-Anne Manski-Nankervis & Mitchell Sarkies (NSW)

The FH Summit was presented as part of the AAS Atherosclerosis Education Program (AEP), with support from our AEP Partners Amgen, AstraZeneca, Novartis and Sanofi.

Familial hypercholesterolaemia in General Practice

8.5 minute video presented by Professor Alistair Vickery:

Familial hypercholesterolaemia What is it? Why does it matter? What can we do?